-
SBI Healthcare Opportunities Fund Regular Growth
Equity healthcare
Overview ( as on 13/01/25 )
NAV
₹417.42
Last change
₹2.7 +0.01%
Fund Size (AUM)
3628.03 Cr
Performance
28.14% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Growth
as of 13/01/25
AUM
3628.03 Cr
Expense Ratio
1.94 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01446
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | 30.62% | 21.31% | 28.14% |
| BSE Healthcare TR INR | 43.51% | 19.99% | 27.52% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.0% |
Max Healthcare Institute Ltd Ordinary Shares |
6.22% |
Divi's Laboratories Ltd |
6.05% |
Cipla Ltd |
5.9% |
Lupin Ltd |
5.19% |
Mankind Pharma Ltd |
4.15% |
Poly Medicure Ltd |
3.6% |
Krishna Institute of Medical Sciences Ltd |
3.46% |
Jupiter Life Line Hospitals Ltd |
3.45% |
Aether Industries Ltd |
3.42% |
Sector Allocation
Healthcare |
93.24% |
Basic Materials |
6.76% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
29.26% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
26.42% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
28.14% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
28.14% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.24% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
29.12% (5Y)
-
